Breaking News
November 19, 2017 - Researchers identify possible genetic basis for coronary artery disease
November 19, 2017 - Stress experienced by emergency call handlers has negative impact on psychological health
November 18, 2017 - New cancer cell screening is improving childhood leukaemia treatment
November 18, 2017 - Groundbreaking study identifies protein as potential factor in cancer metastasis
November 18, 2017 - New model to test effectiveness of existing and potential CF therapies
November 18, 2017 - Staying Active May Lower Odds for Glaucoma
November 18, 2017 - Potential new autism drug shows promise in mice
November 18, 2017 - Some states roll back ‘retroactive Medicaid,’ a buffer for the poor — and for hospitals
November 18, 2017 - Selectively deleting stem cell factor promotes recovery after TBI in mice
November 18, 2017 - Breakthrough research brings new procedure closer to helping patients with blood cancer
November 18, 2017 - Dr Peter Simpson Appointed to SLAS Board of Directors
November 18, 2017 - Friendships between young children can protect against ADHD
November 18, 2017 - Old World monkeys could hold key to stop progression of rheumatoid arthritis
November 18, 2017 - Harris Health System RNs named among 20 Outstanding Nurses for 2017
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study shows how naïve T-cells may affect tumor immunity and immunotherapy
November 18, 2017 - New studies highlight importance of cardiorespiratory fitness to reduce CVD risk
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
November 17, 2017 - Experts identify mental exercise program that can reduce risk of dementia
November 17, 2017 - Just-in-time 3-D implants set to transform tumor surgery
November 17, 2017 - Skin patch offers hope for people with peanut allergy
November 17, 2017 - Scientists identify biomarkers that predict risk of death in Ebola patients
November 17, 2017 - Heart attack, stroke patients have improved outcomes when statins are prescribed after discharge
November 17, 2017 - Majority of people do not understand link between obesity and cancer, study shows
November 17, 2017 - Deep vein thrombosis accurately diagnosed by GPs trained in compression ultrasonography
November 17, 2017 - New Kevlar-based hydrogel recreates the magic of natural cartilage
November 17, 2017 - FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence
November 17, 2017 - Foods made with biofortified corn flour and eggs retain vitamin A after cooking
November 17, 2017 - Integrated Care Winning the Day for Healthcare Companies
November 17, 2017 - CPAP may be superior to gastric banding for severe sleep apnea
November 17, 2017 - New pain relievers reduce opiate overdose risk
November 17, 2017 - Brain astrocytes could play key role in pathogenesis of Alzheimer’s disease
November 17, 2017 - Researchers test whether LVAD surgery could reverse frailty in older adults with heart failure
Treatment proves efficient in subgroup of COPD sufferers

Treatment proves efficient in subgroup of COPD sufferers

image_pdfDownload PDFimage_print
Micrograph appearing emphysema (left – massive empty areas) and lung tissue with relative preservation of the alveoli (proper). Credit score: Wikipedia

An antibody remedy reduces the velocity of flare-u.s.via just about 20 p.c in sufferers with a subgroup of treatment-resistant power obstructive pulmonary illness (COPD), consistent with the result of two massive global trials introduced nowadays on the Eu Breathing Society Global Congress in Milan, Italy, and concurrently printed within the New England Magazine of Medication.

“The purpose of precision drugs is to present the fitting remedy to the fitting affected person,” stated lead creator Frank Sciurba, M.D., director of the Middle for COPD and Emphysema and UPMC Pulmonary Serve as Workout Body structure Laboratory, and visiting professor within the Department of Pulmonary, Hypersensitive reaction, and Crucial Care Medication, College of Pittsburgh Faculty of Medication. “Those findings are the primary instance of a precision treatment this is uniquely efficient in a subgroup of sufferers with treatment-resistant COPD.”

COPD, a revolutionary lung illness characterised via airway obstruction and persistent lung irritation, impacts 30 million American citizens.

“There’s important variation between sufferers within the cells and different proteins liable for lung irritation, so there are if truth be told many various subtypes of COPD,” stated Sciurba.

One subgroup referred to as eosinophilic essential COPD is found in as many as 40 p.c of sufferers and is characterised via increased ranges of a kind of white blood cellular referred to as eosinophils, he stated.

The brand new find out about studies the consequences from two Section III scientific trials comparing the efficacy of mepolizumab, an antibody remedy that reduces the collection of eosinophils within the blood, in reasonable to critical treatment-resistant eosinophilic COPD via blocking off the pro-inflammatory results of interleukin-Five.

Sufferers incorporated within the trials have been nonetheless having spite of a yr of an ordinary remedy referred to as “triple inhaled treatment” that comes with bronchodilators and glucocorticoids.

“Those sufferers have already got been given each remedy we need to be offering them and are nonetheless having flare-u.s.that considerably intervene with their high quality of existence and may end up in deterioration in lung serve as and better mortality,” stated Sciurba. “We was hoping in an effort to be offering them an choice.”

Mepolizumab is already licensed via the Meals and Drug Management (FDA) to cut back symptom flare-u.s.and toughen high quality of existence in eosinophilic bronchial asthma.

The primary trial, termed METREX, used to be carried out at 117 websites in 15 international locations from 2014 to 2017. A complete of 837 COPD sufferers have been stratified via blood eosinophil counts and randomized to obtain both 100 milligrams of mepolizumab or placebo, delivered underneath the outside each 4 weeks for 12 months.

The sufferers with top eosinophil counts who won mepolizumab had a statistically important 18 p.c decrease price of reasonable/critical exacerbations (1.four in keeping with yr in comparison to 1.7 in keeping with yr) than the ones within the placebo workforce. The exacerbation price within the low eosinophil workforce handled with the biologic didn’t vary from placebo. The time to the primary exacerbation additionally used to be upper with mepolizumab than placebo, however most effective within the top eosinophil workforce.

In a 2d, simultaneous trial, termed METREO, the group assessed the impact of a better dose of mepolizumab in 675 sufferers with increased eosinophil ranges. Sufferers have been randomized to obtain 100 or 300 milligrams of mepolizumab or placebo, with the similar supply approach and time table as METREX.

Very similar to METREX, the exacerbation price used to be decreased via 20 p.c within the top eosinophil workforce after 100 milligrams of mepolizumab. The METREO effects narrowly neglected statistical importance. The 300-milligram dose didn’t supply a bonus over the decrease dose.

An research of knowledge from each trials discovered that as baseline blood eosinophil counts greater, so did mepolizumab’s aid in the yearly exacerbation price. This discovering signifies that sufferers with upper preliminary eosinophil counts benefited extra from mepolizumab than the ones with decrease eosinophil counts, Sciurba stated. The security profile of mepolizumab didn’t vary from placebo in both trial.

“Along with offering a brand new remedy choice for sufferers with treatment-resistant, reasonable to critical COPD, the brand new effects are also vital as a result of they establish a possible biomarker for the illness and show that eosinophilic irritation performs a job in COPD,” Sciurba stated.

Pitt’s Department of Pulmonology, Hypersensitive reaction and Crucial Care Medication has a legacy of pioneering remedies for lung illness. UPMC is also house to a number one lung transplant program.

“The findings in those trials exemplify what we are hoping to reach now not most effective in COPD however throughout all lung illnesses when it comes to a precision technique to remedy,” stated department leader, Rama Mallampalli, M.D.

Discover additional:
Mepolizumab is helping sufferers with refractory Churg-Strauss syndrome

Magazine reference:
New England Magazine of Medication

Equipped via:
College of Pittsburgh Colleges of the Well being Sciences

Tagged with:

About author

Related Articles